Australia's largest stock trading and investment forum Australia's #1 stock forum

SUD

0.00%

4.2¢ suda pharmaceuticals ltd

Global Anti-migraine Drugs Market US$ 9.5 Billion by 2025, page-5

First 5 Last

Share
Profile

Follow
Wasabibarako

9,660 Posts.

145

26/03/19

07:52

Post #: 37881067
Share

Originally posted by Bluebush: ↑

Thanks for he kind words old mate, but I really don't know nothin'. I'm still in cause I reckon that there is a chance that we just might jag something (big). Carter's not a sniper, so for him to focus on one product only, would be a mistake. But shotguns are different and even a mug can hit something. Big dog's recent comments about Carter's enthusiasm for Anagrelide could very well be significant. Plenty of irons in the fire at the moment which means there's some redundancy. I reckon stiffy-mist might fall into that category.

A realistic comparison is ACR which peaked at a MC of over 400 million when Eli Lilly started selling their testosterone product. Problem was they only had one product of substance and I think it's fair to say that the FDA investigation into cardio-respiratory issues associated with testosterone supplements as well as the failure to prevent generics in the market killed that run.

Anyway, all good.

Expand

Originally posted by Bluebush: ↑

Thanks for he kind words old mate, but I really don't know nothin'. I'm still in cause I reckon that there is a chance that we just might jag something (big). Carter's not a sniper, so for him to focus on one product only, would be a mistake. But shotguns are different and even a mug can hit something. Big dog's recent comments about Carter's enthusiasm for Anagrelide could very well be significant. Plenty of irons in the fire at the moment which means there's some redundancy. I reckon stiffy-mist might fall into that category.

A realistic comparison is ACR which peaked at a MC of over 400 million when Eli Lilly started selling their testosterone product. Problem was they only had one product of substance and I think it's fair to say that the FDA investigation into cardio-respiratory issues associated with testosterone supplements as well as the failure to prevent generics in the market killed that run.

Anyway, all good.

Expand

Bluebush: "Anyway, all good."

So you guys must really be ENJOYING the new share-price of 0.004.... ?!?

wasa

SUD Price at posting: 0.4¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

CXM

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

There are more pages in this discussion • 4 more messages in this thread...

First 5 Last

Add SUD (ASX) to my watchlist

Global Anti-migraine Drugs Market US$ 9.5 Billion by 2025, page-5

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip